Employees: 28
Size Senvest Capital (SEC.TO) is a Canada Financials company (Financial Conglomerates) with a market value of $745M, the 273rd largest of 405 Canada companies the cockpit tracks. Shares closed at C$442.99 on 18 Nov 2026.
Performance Over six months the shares gained 21.4%, against +0.4% for the median peer and +1.1% for the Canada market (cap-weighted) — 2nd highest of 20 in its peer set.
Growth Revenue fell 16.6% over the last twelve months (peer median +0.8%); the operating margin is 452.6% (peer median 14.5%).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | C$136M | C$154M | C$132M | C$144M | C$77.1M |
| Revenue growth | — | +17% | -8% | +87% | — |
| Gross profit | C$108M | C$129M | C$116M | C$117M | C$41.0M |
| EBITDA | C$616M | C$258M | C$425M | C$213M | -C$335M |
| Net income | C$466M | C$149M | C$258M | C$83.6M | -C$326M |
| Free cash flow | -C$918M | -C$616M | C$508M | -C$441M | -C$227M |
| Capital expenditure | C$0 | C$0 | C$0 | C$0 | C$0 |
| Total debt | C$0 | C$46.6M | C$16.7M | C$7.64M | C$9.18M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SEC.TO | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.5% | +0.1% | 11th highest of 21 |
| 6-month return | +21.4% | +0.4% | 2nd highest of 20 |
| Distance from 52-week high | 0.0% | -11.8% | highest of 21 |
| Revenue growth (TTM) | -16.6% | +0.8% | 2nd lowest of 13 |
| Operating margin | 452.6% | 14.5% | highest of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Senvest Capital SEC.TO | Canada | $745M | +21% | -17% | 453% | n/a | n/a | n/a |
| Patrizia PAT.DE | Germany | $765M | +6% | +19% | 15% | n/a | n/a | n/a |
| Bain Capital Specialty Finance BCSF | United States | $684M | -20% | -8% | 68% | n/a | n/a | n/a |
| MidCap Financial Investment MFIC | United States | $822M | -7% | -4% | 19% | n/a | n/a | n/a |
| Svolder SVOL-A.ST | Sweden | $667M | +42% | +1,360% | 90% | n/a | n/a | n/a |
| Drugs Made In America Acquisition II DMII | United States | $652M | +2% | n/a | n/a | n/a | n/a | n/a |
| Monex 8698.T | Japan | $884M | -14% | +4% | 14% | n/a | n/a | n/a |
| Metalla Royalty & Streaming MTA.V | Canada | $616M | +2% | +56% | 17% | n/a | n/a | n/a |
| KB Balhae Infrastructure Fund 415640.KS | South Korea | $911M | +1% | n/a | n/a | n/a | n/a | n/a |
| EQV Ventures Acquisition Corp. II EVAC | United States | $606M | +2% | n/a | n/a | n/a | n/a | n/a |
| Bain Capital GSS Investment BCSS | United States | $604M | +2% | n/a | n/a | n/a | n/a | n/a |
| L1 Gold Fund LGF.AX | Australia | $926M | +11% | n/a | n/a | n/a | n/a | n/a |
| Cantor Equity Partners IV CEPF | United States | $591M | 0% | n/a | n/a | n/a | n/a | n/a |
| OIO OIO | United States | $584M | -5% | -4% | -85% | n/a | n/a | n/a |
| Churchill Capital Corp XII CXII | United States | $577M | n/a | n/a | n/a | n/a | n/a | n/a |
| Pacific Century Regional Developments P15.SI | Singapore | $965M | 0% | -37% | -70% | n/a | n/a | n/a |
| Mbb MBB.DE | Germany | $968M | +11% | 0% | 12% | n/a | n/a | n/a |
| Luyin Investment 600784.SS | China | $563M | -28% | +4% | 5% | n/a | n/a | n/a |
| International General Insurance IGIC | United States | $1.01B | -5% | +2% | 20% | n/a | n/a | n/a |
| RMR RMR | United States | $546M | -14% | -8% | 10% | n/a | n/a | n/a |
| American Exceptionalism Acquisition AEXA | United States | $526M | -7% | n/a | n/a | n/a | n/a | n/a |